Compounds > dronabinol
Page last updated: 2024-08-21

dronabinol and Acute Myelogenous Leukemia

dronabinol has been researched along with Acute Myelogenous Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akmut, F; Illing, B; Kampa-Schittenhelm, KM; Kanz, L; Salih, HR; Salitzky, O; Schittenhelm, MM1
Chubb, CB; Gemmell, MA; Huberman, E; Maeda, S; Murison, G1

Other Studies

3 other study(ies) available for dronabinol and Acute Myelogenous Leukemia

ArticleYear
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.
    BMC cancer, 2016, Jan-16, Volume: 16

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Dronabinol; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2016
Letter: Tetrahydrocannabinol and chemotherapy.
    The New England journal of medicine, 1976, Jan-15, Volume: 294, Issue:3

    Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting

1976
Cannabinoids induce incomplete maturation of cultured human leukemia cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:15

    Topics: Calcitriol; Cannabidiol; Cannabinoids; Cannabinol; Cell Differentiation; Cells, Cultured; Dronabinol; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Monocytes; Tetradecanoylphorbol Acetate

1987